Please login to the form below

Not currently logged in
Email:
Password:

Cell Therapeutics Inc

This page shows the latest Cell Therapeutics Inc news and features for those working in and with pharma, biotech and healthcare.

CTI launches cancer drug Pixuvri in UK

CTI launches cancer drug Pixuvri in UK

Now available to treat form of non-Hodgkin lymphoma. Cell Therapeutics Inc (CTI) has launched its cancer treatment Pixuvri in the UK. ... Pixuvri (pixantrone) becomes the first drug available in the UK as a monotherapy treatment option for adults with

Latest news

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Deal Watch February 2016 Deal Watch February 2016

    licence, collaboration expanded. 830. Adaptimmune Therapeutics/ GSK. TCR engineered T-cell therapies inc affinity enhanced T-cell immunotherapy targeting NY-ESO-1 (p1/2); 4 other progs and combination studies. ... acquisition - product. 190. Annapurna

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics